Brynjelsen Sean insider trades
Brynjelsen Sean has filed 14 Form 4s with the SEC that we hold, all for Eton Pharmaceuticals, Inc. (ETON), as President & CEO, Director. Across all of them we count 2 purchases worth $64.2K and 11 sales worth $13.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($9.9M). The largest single trade was a sale of 119,852 shares of Eton Pharmaceuticals, Inc. worth $3.8M, dated 2026-05-28. Of 4 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-20 and the latest 2026-08-20.
Eton Pharmaceuticals, Inc. (ETON)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-20 | P, purchase reported on Form 4 | 10,000 | $43.2K | 2021-08-20 |
| 2022-09-22 | P, purchase reported on Form 4 | 10,000 | $21.0K | 2022-09-23 |
| 2025-06-03 | S, sale reported on Form 4 | 8,655 | $159.1K | 2025-06-05 |
| 2025-06-03 | S, sale reported on Form 4 | 60,945 | $1.1M | 2025-06-05 |
| 2025-06-03 | S, sale reported on Form 4 | 400 | $7.6K | 2025-06-05 |
| 2025-06-04 | S, sale reported on Form 4 | 70,000 | $1.2M | 2025-06-05 |
| 2025-06-05 | S, sale reported on Form 4 | 70,000 | $1.2M | 2025-06-05 |
| 2026-05-28 | S, sale reported on Form 4 | 148 | $4.8K | 2026-05-29 |
| 2026-05-28 | S, sale reported on Form 4 | 119,852 | $3.8M | 2026-05-29 |
| 2026-08-19 | S, sale reported on Form 4 | 8,978 | $562.5K | 2026-08-20 |
| 2026-08-20 | S, sale reported on Form 4 | 47,307 | $2.8M | 2026-08-20 |
| 2026-08-20 | S, sale reported on Form 4 | 36,373 | $2.2M | 2026-08-20 |
| 2026-08-20 | S, sale reported on Form 4 | 7,342 | $456.1K | 2026-08-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1669976) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms